Replies to post #80 on NanoLogix Inc (NNLX)

[rwdj101]

I agree. It may have something to do with their Nutra Pharma deal announced on January 25, 2006.

In Nanologix's agreement with Nutra Pharma, "NanoLogix will reassign to Nutra Pharma 11 key patents protecting the diagnostics test kit technology in exchange for Nutra Pharma's entire holding of NanoLogix stock (over 4.5 million shares)."

Shortly afterwards, NNLX's stock price began to decline (dilution of the 4.5 million shares?) until it hit an annual low of roughly .05 per share.

Also, many of Nanologix's press releases tend to relate to procedural issues (ie, "new director," "strategic agreement," "fully reporting status," etc.) at a time when investors are looking for substantive answers relating to their hydrogen plans.

They really need to address issues such as those discussed in Harry Wickey's post (#61) http://www.investorshub.com/boards/read_msg.asp?message_id=10464926

In addition, where's the press coverage beyond their "press releases?" Any firm can release news via PR Newswire and Business Wire. I would think that an innovation such as low-cost hydrogen production would make the cover of the New York Times.

Nevertheless, I believe that if they can properly address these issues, the stock should do fine.

RWDJ101

[Rocky77]

I understand what you mean. I still don't think it's dilution, although Matt could very well have been lying to me. I just think the volatility of this stock is great enough to sink back down unless buyers are lining up, which won't happen until next week. If I wasn't already at my self imposed 100k limit, I'd def buy more.